Saudi Journal for Health Sciences

REVIEW ARTICLE
Year
: 2022  |  Volume : 11  |  Issue : 2  |  Page : 83--90

Recent update on treatment and preventive modalities for COVID-19 Omicron variant (B.1.1.529) in India: A comprehensive review


Deep Inder1, Seema Manak1, Md Faiz Akram1, Pawan Kumar2 
1 Department of Pharmacology, FOD, Jamia Millia Islamia, Delhi, India
2 Additional Director, Directorate General of Health Services (DGHS), Delhi, India

Correspondence Address:
Md Faiz Akram
Department of Pharmacology, FOD, Jamia Millia Islamia, New Delhi - 110 025
India

In India, Omicron (B1.1.529), a variant of concern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has challenged the existing drug treatments options and available vaccines. Extensive search has been done to review updated information through original research articles, meta-analysis, and case reports available at EMBASE, SCOPUS, and Google Scholar, for treatment and preventive strategies against Omicron. Excessive mutations in SARS-CoV-2 (Omicron) led to immune escape witnessed for monoclonal antibodies, leaving very limited drug options to treat Omicron infected patients. Protection offered by existing vaccines appeared as a matter of concern as far as efficacy against Omicron is concerned. Although vaccination will not prevent re-infection in actively and passively immunized individual, but will prevent serious respiratory illness and death. The current review article imparts knowledge regarding pharmacotherapeutic agents, showing promise against Omicron. The present review also highlights updated data on newer vaccine candidates for their safety and efficacy for Omicron, based on postmarketing surveillance and Phase III clinical trials across the globe. There is a need to generate more data on drugs as well as vaccines specifically targeting Omicron, in order to contain SARS-CoV-2 new variant.


How to cite this article:
Inder D, Manak S, Akram MF, Kumar P. Recent update on treatment and preventive modalities for COVID-19 Omicron variant (B.1.1.529) in India: A comprehensive review.Saudi J Health Sci 2022;11:83-90


How to cite this URL:
Inder D, Manak S, Akram MF, Kumar P. Recent update on treatment and preventive modalities for COVID-19 Omicron variant (B.1.1.529) in India: A comprehensive review. Saudi J Health Sci [serial online] 2022 [cited 2022 Sep 27 ];11:83-90
Available from: https://www.saudijhealthsci.org/article.asp?issn=2278-0521;year=2022;volume=11;issue=2;spage=83;epage=90;aulast=Inder;type=0